Chengdu Institute of Biology developed a new method for 2D-1D-2D mass spectrometry imaging
Time of Update: 2022-02-17
The team of researcher Zhou Yan of Chengdu Institute of Biology, Chinese Academy of Sciences has successfully developed a 2D-1D-2D mass spectrometry imaging technology based on line sampling mass spectrometry, which can be used for imaging analysis of large-scale and uneven biological samples .
What causes the unusual intestinal obstruction that confuses the doctor
Time of Update: 2021-10-22
Postoperative pathological return: Goblet cell adenocarcinoma of the appendix is grade 3, invading the entire thickness of the appendix wall and involving the serosal surface, and the cancer tissue infiltrating the entire thickness of the ileocecal intestinal wall .
MaxDIA: Taking proteomics to a new level
Time of Update: 2021-08-02
Two Methods of Analyzing Proteins by Mass SpectrometryShotgun proteomics mainly uses two methods: Data Dependent Acquisition (DDA) and Data Independent Acquisition (DIA) .
Combine DDA and DIAJürgen Cox and his team have now developed a software that provides a complete calculation workflow for DIA data .
Eur Radiol: How much do you know about MRI diagnosis of ovarian tumors
Time of Update: 2021-03-20
diagnosis Recently, a study published in the journal European Radiology has developed a deep learning algorithm that uses convolutional neural networks on conventional MR imaging to identify benign and malignant ovarian lesions, and establishes a preoperative evaluation of non-invasive ovarian lesions.
Cell Death Dis: CtBP determines fate of ovarian cancer cells by suppressing DRs
Time of Update: 2020-05-29
High-level plasma ovary cancer (HGSOC) is a complex heterogeneous disease that accounts for 70% of epithelial ovarian cancer and is still the deadliest gynecological malignancies The main treatment